1-3 of 3
Anne-Laure Roupie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients

Maureen Chbat, Milena Kohn, Fatiha Merabet, Anne-Laure Roupie, Naelle Lombion, Amina Guemriche, Stéphanie Marque-Juillet, Victoria Raggueneau, Jennifer Osman, Marc Spentchian, Marc Delord, Sophie Rigaudeau, Caroline Besson
Journal: Blood
Blood (2021) 138 (Supplement 1): 3751.
https://doi.org/10.1182/blood-2021-150298
Published: 2021
Journal Articles

Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a

Clinical Trials & Observations
Alfonso Quintás-Cardama, Omar Abdel-Wahab, Taghi Manshouri, Outi Kilpivaara, Jorge Cortes, Anne-Laure Roupie, Su-Jiang Zhang, David Harris, Zeev Estrov, Hagop Kantarjian, Ross L. Levine, Srdan Verstovsek
Journal: Blood
Blood (2013) 122 (6): 893–901.
https://doi.org/10.1182/blood-2012-07-442012
Published: 2013
Includes: Supplemental data
Journal Articles

Dynamics of Mutant Alleles in Patients with Advanced Essential Thrombocythemia (ET) or Polycythemia (PV) During Pegylated Interferon-Alfa-2A (PEG-IFN-α-2A; Pegasys) Therapy

Alfonso Quintas-Cardama, MD, Omar Abdel-Wahab, MD, Ross L Levine, MD, Taghi Manshouri, PhD, Anne-Laure Roupie, Hagop M. Kantarjian, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 281.
https://doi.org/10.1182/blood.V118.21.281.281
Published: 2011